Cosmos Health Inc. (NASDAQ:COSM – Get Free Report) CEO Grigorios Siokas purchased 38,900 shares of Cosmos Health stock in a transaction dated Wednesday, January 22nd. The shares were bought at an average price of $0.77 per share, for a total transaction of $29,953.00. Following the acquisition, the chief executive officer now owns 4,203,689 shares in the company, valued at approximately $3,236,840.53. This trade represents a 0.93 % increase in their ownership of the stock. The purchase was disclosed in a legal filing with the SEC, which is accessible through the SEC website.
Grigorios Siokas also recently made the following trade(s):
- On Friday, January 17th, Grigorios Siokas bought 29,158 shares of Cosmos Health stock. The shares were purchased at an average price of $0.86 per share, with a total value of $25,075.88.
- On Wednesday, January 15th, Grigorios Siokas acquired 62,500 shares of Cosmos Health stock. The stock was acquired at an average price of $0.80 per share, for a total transaction of $50,000.00.
- On Monday, January 13th, Grigorios Siokas purchased 163,666 shares of Cosmos Health stock. The shares were bought at an average price of $0.61 per share, for a total transaction of $99,836.26.
- On Friday, December 20th, Grigorios Siokas bought 257,334 shares of Cosmos Health stock. The stock was acquired at an average cost of $0.58 per share, for a total transaction of $149,253.72.
Cosmos Health Price Performance
Cosmos Health stock traded down $0.01 during midday trading on Thursday, reaching $0.77. The company’s stock had a trading volume of 118,803 shares, compared to its average volume of 884,276. The stock’s 50 day simple moving average is $0.72 and its 200 day simple moving average is $0.91. The firm has a market capitalization of $17.79 million, a PE ratio of -0.31 and a beta of 5.57. Cosmos Health Inc. has a fifty-two week low of $0.47 and a fifty-two week high of $1.58. The company has a debt-to-equity ratio of 0.08, a quick ratio of 1.24 and a current ratio of 1.44.
Cosmos Health Company Profile
Cosmos Health Inc manufactures, develops, and trades branded nutraceutical products in Greece, the United Kingdom, Croatia, Bulgaria, Cayman Islands, and Cyprus. It offers medicines, OTC medicines, nutraceutical products, vitamins, minerals and dietary, health care products, medical devices, baby products, and others under the Sky Premium Life and Mediterranation brand names.
Recommended Stories
- Five stocks we like better than Cosmos Health
- How to Buy Cheap Stocks Step by Step
- Momentum Builders: 3 Stocks Positioned to Shine This Quarter
- Dividend Screener: How to Evaluate Dividend Stocks Before Buying
- GitLab: AI-Driven DevSecOps Innovation Sets It Apart
- What is the Nikkei 225 index?
- DigitalOcean’s AI Potential: A Game-Changer for Growth
Receive News & Ratings for Cosmos Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Cosmos Health and related companies with MarketBeat.com's FREE daily email newsletter.